Poly(ADP-ribose) polymerase inhibition as a novel therapeutic approach against intraepidermal nerve fiber loss and neuropathic pain associated with advanced diabetic neuropathy: a commentary on "PARP Inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy"
- PMID: 18194675
- PMCID: PMC2322872
- DOI: 10.1016/j.freeradbiomed.2007.12.020
Poly(ADP-ribose) polymerase inhibition as a novel therapeutic approach against intraepidermal nerve fiber loss and neuropathic pain associated with advanced diabetic neuropathy: a commentary on "PARP Inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy"
Comment on
-
PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy.Free Radic Biol Med. 2008 Mar 15;44(6):972-81. doi: 10.1016/j.freeradbiomed.2007.09.013. Epub 2007 Oct 3. Free Radic Biol Med. 2008. PMID: 17976390 Free PMC article.
Similar articles
-
PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy.Free Radic Biol Med. 2008 Mar 15;44(6):972-81. doi: 10.1016/j.freeradbiomed.2007.09.013. Epub 2007 Oct 3. Free Radic Biol Med. 2008. PMID: 17976390 Free PMC article.
-
PARP inhibitors attenuate chemotherapy-induced painful neuropathy.J Peripher Nerv Syst. 2012 Sep;17(3):324-30. doi: 10.1111/j.1529-8027.2012.00413.x. J Peripher Nerv Syst. 2012. PMID: 22971094
-
Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.Diabetologia. 2004 Apr;47(4):710-7. doi: 10.1007/s00125-004-1356-0. Diabetologia. 2004. PMID: 15298348
-
Poly(ADP-ribose)polymerase inhibition - where now?Curr Med Chem. 2005;12(20):2373-92. doi: 10.2174/0929867054864778. Curr Med Chem. 2005. PMID: 16181138 Review.
-
Poly (ADP-ribose) polymerase: An Overview of Mechanistic Approaches and Therapeutic Opportunities in the Management of Stroke.Neurochem Res. 2022 Jul;47(7):1830-1852. doi: 10.1007/s11064-022-03595-z. Epub 2022 Apr 18. Neurochem Res. 2022. PMID: 35437712 Review.
Cited by
-
Mechanisms of disease: the oxidative stress theory of diabetic neuropathy.Rev Endocr Metab Disord. 2008 Dec;9(4):301-14. doi: 10.1007/s11154-008-9104-2. Rev Endocr Metab Disord. 2008. PMID: 18709457 Free PMC article. Review.
-
Neuropathic Pain: Delving into the Oxidative Origin and the Possible Implication of Transient Receptor Potential Channels.Front Physiol. 2018 Feb 14;9:95. doi: 10.3389/fphys.2018.00095. eCollection 2018. Front Physiol. 2018. PMID: 29491840 Free PMC article. Review.
-
Lysophosphatidic Acid Receptor 1- and 3-Mediated Hyperalgesia and Hypoalgesia in Diabetic Neuropathic Pain Models in Mice.Cells. 2020 Aug 16;9(8):1906. doi: 10.3390/cells9081906. Cells. 2020. PMID: 32824296 Free PMC article.
References
-
- Said G. Diabetic neuropathy-a review. Nat Clin Pract. 2007;3:331–340. - PubMed
-
- Obrosova IG. Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications. Antioxid Redox Signal. 2005;7:1543–1552. - PubMed
-
- Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615–1625. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical